The company's flagship product is BrainHQ, a software package designed to improve memory, attention, mental processing speed, interpersonal skills, and overall intelligence.
Under development is a computer game that the company hopes will be the first software to be approved by the Food and Drug Administration for treating schizophrenia [REF].